75 related articles for article (PubMed ID: 20646020)
1. Cervical cancer: cytological cervical screening in Iceland and implications of HPV vaccines.
Sigurdsson K
Cytopathology; 2010 Aug; 21(4):213-22. PubMed ID: 20646020
[TBL] [Abstract][Full Text] [Related]
2. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention.
Jenkins D
Gynecol Oncol; 2008 Sep; 110(3 Suppl 1):S18-25. PubMed ID: 18653221
[TBL] [Abstract][Full Text] [Related]
3. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
Adams M; Jasani B; Fiander A
Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
[TBL] [Abstract][Full Text] [Related]
4. Prevention of cervical cancer in rural China: evaluation of HPV vaccination and primary HPV screening strategies.
Canfell K; Shi JF; Lew JB; Walker R; Zhao FH; Simonella L; Chen JF; Legood R; Smith MA; Nickson C; Qiao YL
Vaccine; 2011 Mar; 29(13):2487-94. PubMed ID: 21211586
[TBL] [Abstract][Full Text] [Related]
5. Cervical screening in the era of HPV vaccination.
Farnsworth A
Cytopathology; 2010 Aug; 21(4):211-2. PubMed ID: 20646019
[No Abstract] [Full Text] [Related]
6. Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening.
Arbyn M; Dillner J
J Clin Virol; 2007 Mar; 38(3):189-97. PubMed ID: 17258503
[TBL] [Abstract][Full Text] [Related]
7. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
Schindeler S; Morrell S; Zuo Y; Baker D
J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic HPV vaccination for women over 18 years of age.
Adams M; Jasani B; Fiander A
Vaccine; 2009 May; 27(25-26):3391-4. PubMed ID: 19200838
[TBL] [Abstract][Full Text] [Related]
9. Chapter 30: HPV vaccines and screening in the prevention of cervical cancer; conclusions from a 2006 workshop of international experts.
Wright TC; Bosch FX; Franco EL; Cuzick J; Schiller JT; Garnett GP; Meheus A
Vaccine; 2006 Aug; 24 Suppl 3():S3/251-61. PubMed ID: 16950014
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses.
Barnabas RV; Laukkanen P; Koskela P; Kontula O; Lehtinen M; Garnett GP
PLoS Med; 2006 May; 3(5):e138. PubMed ID: 16573364
[TBL] [Abstract][Full Text] [Related]
11. [Can human papillomavirus testing and vaccination prevent cervical cancer?].
Lie AK; Bjørge T; Helland A; Hagen B; Skjeldestad FE; Hagmar B; Thoresen S
Tidsskr Nor Laegeforen; 2001 Oct; 121(25):2947-51. PubMed ID: 11715778
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
Tay SK; Ngan HY; Chu TY; Cheung AN; Tay EH
Vaccine; 2008 Aug; 26 Suppl 12():M60-70. PubMed ID: 18945415
[TBL] [Abstract][Full Text] [Related]
13. Eligibility and willingness of young Icelandic women to participate in a HPV vaccination trial.
Gudmundsdóttir T; Tryggvadóttir L; Allende M; Mast TC; Briem H; Sigurdsson K
Acta Obstet Gynecol Scand; 2003 Apr; 82(4):345-50. PubMed ID: 12716319
[TBL] [Abstract][Full Text] [Related]
14. Integrating human papillomavirus vaccination in cervical cancer control programmes.
Franco EL; Coutlée F; Ferenczy A
Public Health Genomics; 2009; 12(5-6):352-61. PubMed ID: 19684447
[TBL] [Abstract][Full Text] [Related]
15. [Cervical cancer prevention: the impact of HPV vaccination].
Monsonégo J
Gynecol Obstet Fertil; 2006 Mar; 34(3):189-201. PubMed ID: 16529969
[TBL] [Abstract][Full Text] [Related]
16. Clinical update of the AS04-adjuvanted human papillomavirus-16/18 cervical cancer vaccine, Cervarix.
Schwarz TF
Adv Ther; 2009 Nov; 26(11):983-98. PubMed ID: 20024678
[TBL] [Abstract][Full Text] [Related]
17. The current and future role of screening in the era of HPV vaccination.
Myers E; Huh WK; Wright JD; Smith JS
Gynecol Oncol; 2008 May; 109(2 Suppl):S31-9. PubMed ID: 18482556
[TBL] [Abstract][Full Text] [Related]
18. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
[TBL] [Abstract][Full Text] [Related]
19. Advances in primary and secondary interventions for cervical cancer: human papillomavirus prophylactic vaccines and testing.
Wheeler CM
Nat Clin Pract Oncol; 2007 Apr; 4(4):224-35. PubMed ID: 17392713
[TBL] [Abstract][Full Text] [Related]
20. The Icelandic and Nordic cervical screening programs: trends in incidence and mortality rates through 1995.
Sigurdsson K
Acta Obstet Gynecol Scand; 1999 Jul; 78(6):478-85. PubMed ID: 10376856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]